priviahealth.com - PRVA Enterprise Value-to-Revenue Multiple

Official company branding of priviahealth.com (PRVA)

The change in the EV/Sales multiple for Privia Health Group (PRVA) is based on cloud outsourcing of patient data, which drives the valuation dynamics. Effective management is implementing value-based payment models, while the integration of AI into predictive analytics optimizes physician routines. The current 1139.31 determines the metric's magnitude, reflecting the transparency of the company's sales within a prolonged sideways corridor on the chart.

PRVA Privia Medical Group Enterprise Value-to-Revenue Ratio (11/23/2025 - 11/20/2026)

Privia Health Corp - analytical breakdowns and key metrics (PRVA)

Fundamental valuation:Privia Health Group PRVA
Manufactured products of Privia Health Group, Inc.

This metric measures the total enterprise value, including debt, relative to generated sales volume, revealing the extent to which the market is overpaying per unit of revenue. A rising EV/Sales ratio signals inflated expectations, which is critical for Privia Health Group (PRVA), as its capitalization depends directly on the scaling efficiency of its technological platform and the expansion of its partnership network with medical centers.

Competitor analysis for Privia Health Group

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Waystar Inc.|CRVL: Business Value to Revenue|Company Value to Revenue HURN (Huron Corp)|Company Value to Revenue Certara CERT|EV/Sales Multiple OMCL (Omnicell Inc)|Total Company Value-to-Revenue Ratio GoodRx Inc (GDRX)|Schrodinger Corp - EV/Sales Multiple|Enterprise Value to Sales Volume PHR|OMDA: EV/Sales Multiple|Evolent Health, Inc. - Business Value to Revenue|Enterprise Value-to-Revenue Ratio HealthStream Corp|DH: Business Value to Revenue|Company Value to Revenue CCSI (Consensus)|Total Company Value-to-Revenue Ratio Agilon Health|EV/Sales Multiple ABSI (Absci)|soyoung.com (SY) - Enterprise Value-to-Revenue Multiple|NRC - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Spok Holdings Inc SPOK|OPRX (OptimizeRx) - Company Value to Revenue|TBRG - Total Company Value-to-Revenue Ratio|Company Value to Revenue SLP|Enterprise Value-to-Revenue Multiple sophiagenetics.com SOPH|EV/Sales Multiple HCAT|CCLD (CareCloud Inc.) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Research Solutions Inc. RSSS|DLHC - Company Value to Revenue|ONMD - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Scienture Holdings Inc SCNX|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)